当前位置:
X-MOL 学术
›
J. Diabetes Investig.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development.
Journal of Diabetes Investigation ( IF 3.1 ) Pub Date : 2019-12-22 , DOI: 10.1111/jdi.13188 Tatsuhito Himeno 1 , Hideki Kamiya 1 , Jiro Nakamura 1
Journal of Diabetes Investigation ( IF 3.1 ) Pub Date : 2019-12-22 , DOI: 10.1111/jdi.13188 Tatsuhito Himeno 1 , Hideki Kamiya 1 , Jiro Nakamura 1
Affiliation
Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point‐of‐care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneuropathy.
中文翻译:
糖尿病多发性神经病:诊断策略和新靶标发现方面的进展,但药物开发停滞。
糖尿病多发性神经病的诊断策略已经取得进展。尤其是,巴巴通过神经传导研究和神经传导研究的护理设备对糖尿病多发性神经病的严重程度进行分类,将实现对糖尿病多发性神经病的客观定量评估。
更新日期:2019-12-22
中文翻译:
糖尿病多发性神经病:诊断策略和新靶标发现方面的进展,但药物开发停滞。
糖尿病多发性神经病的诊断策略已经取得进展。尤其是,巴巴通过神经传导研究和神经传导研究的护理设备对糖尿病多发性神经病的严重程度进行分类,将实现对糖尿病多发性神经病的客观定量评估。